We are live on ! Find out more
ABMD

Abiomed Inc
ABMD

Delisted

ABMD was delisted on the 21st of December, 2022.

Back to rankings

8 hedge funds and large institutions have $4.62M invested in Abiomed Inc in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 499 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

98% less funds holding

Funds holding: 517 → 8 (-509)

99% less call options, than puts

Call options by funds: $437K | Put options by funds: $45.7M

100% less capital invested

Capital invested by funds: $10.5B → $4.62M (-$10.5B)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 499

Holders
8
Holders Change
-509
Holders Change %
-98.45%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
6
Closed
499
Calls
$437K
Puts
$45.7M
Net Calls
-$45.2M
Net Calls Change
-$79.7M

Top Buyers

Rank Fund Capital Flow
1
BTI
Blue Trust Inc
Georgia
+$14K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$1.29B
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$1.21B
3
BlackRock
BlackRock
New York
-$1.12B
4
State Street
State Street
Massachusetts
-$509M
5
Primecap Management
Primecap Management
California
-$370M
Name Holding Trade Value Shares
Change 		Change in
Stake
S
426
SignatureFD
Georgia
– -$48K -196 Closed
VC
427
Vestor Capital
Illinois
– -$47K -191 Closed
WPWM
428
Western Pacific Wealth Management
Illinois
– -$46K -189 Closed
PA
429
Parallel Advisors
California
– -$45K -184 Closed
TFA
430
Toth Financial Advisory
Virginia
– -$44K -180 Closed
GEA
431
Glen Eagle Advisors
New Jersey
– -$41.8K -170 Closed
Bessemer Group
432
Bessemer Group
New Jersey
– -$40K -162 Closed
National Bank of Canada
433
National Bank of Canada
Quebec, Canada
– -$40K -161 Closed
HI
434
Harbour Investments
Wisconsin
– -$39K -158 Closed
DIP
435
DT Investment Partners
Pennsylvania
– -$34K -140 Closed
Loomis, Sayles & Company
436
Loomis, Sayles & Company
Massachusetts
– -$34K -139 Closed
TWA
437
TCI Wealth Advisors
Arizona
– -$31K -125 Closed
JWM
438
Janiczek Wealth Management
Colorado
– -$31K -124 Closed
HL
439
Harding Loevner
New Jersey
– -$29K -118 Closed
TFM
440
TFC Financial Management
Massachusetts
– -$29K -117 Closed
ODG
441
O'Dell Group
Ohio
– -$28K -113 Closed
ACM
442
Aquatic Capital Management
Illinois
– -$25K -100 Closed
CHC
443
City Holding Co
West Virginia
– -$25K -100 Closed
GWM
444
Geneos Wealth Management
Colorado
– -$24K -100 Closed
LJHT
445
Laurie J. Hall Trustee
– -$25K -100 Closed
LS
446
Livforsakringsbolaget Skandia
Sweden
– -$25K -100 Closed
SWM
447
Sugarloaf Wealth Management
Georgia
– -$25K -100 Closed
LC
448
Lindbrook Capital
California
– -$23K -94 Closed
CFO
449
CVA Family Office
Colorado
– -$22K -90 Closed
GWSG
450
GPS Wealth Strategies Group
Colorado
– -$18K -73 Closed
16 17
18
19 20

ABMD Hedge Fund Activity: Q4 2022 in Review

8 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2022, worth a combined $4.62M — down 100% from $10.5B a quarter earlier.

Sellers outnumbered buyers: 499 funds closed out of ABMD and 0 opened new positions — a net loss of 499 holders — while 6 trimmed existing stakes and 1 added.

The largest buyer was Blue Trust Inc, adding an estimated $14K. The largest seller was Vanguard Group, exiting entirely with an estimated $1.29B sold.

  • 8 institutional investors held Abiomed Inc (ABMD) as of Q4 2022, down from 517 in Q3 2022.
  • Funds reported $4.62M of Abiomed Inc stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Abiomed Inc positions in Q4 2022 and 499 closed out, a net change of -499 holders.
  • The largest Abiomed Inc buyer in Q4 2022 was Blue Trust Inc, an estimated $14K added.
  • The largest Abiomed Inc seller in Q4 2022 was Vanguard Group, an estimated $1.29B sold.

Based on aggregated 13F filings for Q4 2022.